• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORP. LIPOSORBER LA-15 SYSTEM; LIPOPROTEIN, LOW DENSITY, REMOVAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORP. LIPOSORBER LA-15 SYSTEM; LIPOPROTEIN, LOW DENSITY, REMOVAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Sudden Cardiac Death (2510)
Event Date 12/04/2015
Event Type  Death  
Manufacturer Narrative
On the previous day of the event ldl-apheresis with the concerned device was completed without any complication.Next day, the patient completed hemodialysis and spent hours in his patient's room normally before the event occurred.Then, the patient suddenly lost consciousness and entered into cardiopulmonary arrest.Therefore, it is speculated that sudden death occurred after some catastrophic events.No information about the cause of death of the patient was provided.On fsgs, the causes of death in general are reported as follows: malignant tumors for 1.4%, infectious disease for 0.7%, abdominal aortic aneurysm-rupture for 0.4%, heart failure for 0.4%, and sudden death for 0.4%.(the japanese journal of nephrology, vol.44, pp 751-761, 2002.) although the physician in charge commented that ldl-apheresis could not be relevant to the patient's death, we cannot completely exclude a possibility that ldl-apheresis and/or hemodialysis is relevant to the catastrophic events occurred.
 
Event Description
A maintenance hemodialysis patient with new-onset of focal glomerulosclerosis (fsgs).No other complications were observed.As steroid was not effective on fsgs, ldl-apheresis therapy using the liposorber a-15 system was commenced.On (b)(6) his 8th ldl-apheresis was conducted.On (b)(6) he underwent hemodialysis without any complication, returned to his patient's room and took a meal.He had a conversation normally, although he confessed slightly ill.Then, he suddenly lost consciousness at 15:30, and suffered cardiopulmonary arrest.He recovered once after resuscitation, but died at 16:07.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPOSORBER LA-15 SYSTEM
Type of Device
LIPOPROTEIN, LOW DENSITY, REMOVAL
Manufacturer (Section D)
KANEKA CORP.
2-3-18,nakanoshima,kita-ku
osaka 530-8 288
JA  530-8288
Manufacturer Contact
kazuhiko inoue
2-3-18, nakanoshima,kita-ku
osaka-city 530-8-288
JA   530-8288
4613072
MDR Report Key6183187
MDR Text Key62669501
Report Number9614654-2016-00001
Device Sequence Number1
Product Code MMY
UDI-Device Identifier14993478010110
UDI-Public14993478010110
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P910018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/09/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/09/2015
Initial Date FDA Received12/16/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
APHERESIS MACHINE KANEKA MA-03; SULFLUX PLASMA SEPARATOR; TUBING SYSTEM FOR PLASMAPHERESIS NK-M3R
Patient Outcome(s) Death;
Patient Age72 YR
Patient Weight47
-
-